WHO Endorses New Obesity Treatment Options

 



Recently, the World Health Organization (WHO) approved GLP-1 receptor agonists as a treatment for obesity, such as semaglutide and tirzepatide, to mimic hormones that regulate appetite and blood sugar. The WHO emphasizes that while healthy eating and exercise are crucial, they alone cannot solve the obesity epidemic.

Global Obesity Statistics

Obesity is a pressing global issue. In 2022, one in eight people worldwide was classified as obese, totaling 890 million adults and 160 million adolescents. Since 1990, obesity rates among adults have doubled, while rates among adolescents have quadrupled. In India, 44 million women and 26 million men were affected by obesity in 2022. Childhood obesity has also surged, from 0.2 million obese children in 1990 to 12.5 million in 2022.

Economic Impact of Obesity

The financial burden of obesity is staggering. Global healthcare costs related to obesity are projected to reach $3 trillion by 2030. In nations where 30% of the population is obese, healthcare expenses could consume 18% of national budgets. Obesity also contributes to mortality, causing 5 million deaths from non-communicable diseases in 2019, representing 12% of all such deaths.

Development of GLP-1 Medications

As patents for semaglutide near expiration in countries like India and Brazil, local manufacturers are working on generic versions. Additionally, more GLP-1-based medications are in development globally. Notable examples include Novo Nordisk’s Ozempic, originally for type 2 diabetes, which gained popularity for weight loss. Wegovy, another semaglutide formulation, was approved for chronic weight management in 2021. Eli Lilly’s Zepbound, approved in 2023, also addresses obesity.

The WHO plans to release guidelines for the safe and effective use of GLP-1 receptor agonists in adults with obesity. These guidelines are expected in July 2025 and will aim to standardise treatment protocols worldwide.

#BodyPositivity
#SelfLove
#LoveYourself
#EmbraceYourCurves
#BeYourOwnKindOfBeautiful
#BodyConfidence
#CelebrateYourBody
#SelfAcceptance
#HealthyBodyHealthyMind
#OwnYourBeauty

World Cell Biologist Awards:

Website Link : cellbiologist.org 
Nomination Link : cellbiologist.org/award-nomination/?ecategory=Awards&rcategory=Awardee Contact Us: contact@cellbiologist.org

Follow Us On :
Twitter : twitter.com/account/access 
Blogger : blogger.com/u/1/blog/posts/1155994660171864058
Pinterest :pinterest.com/researchs625/?actingBusinessId=907757006050531250
Linkedin : .linkedin.com/in/research-scholar-10278a323/
Tumblr ; tumblr.com/

Comments

Post a Comment

Popular posts from this blog

Guillain-Barré Syndrome Cases in Andhra Pradesh

Image
  Recently, the state of Andhra Pradesh has witnessed a rise in Guillain-Barré Syndrome (GBS) cases, prompting government action. The Chief Minister has ordered an investigation into the outbreak. Earlier this year, Maharashtra also reported rising cases of GBS. About Guillain-Barré Syndrome Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder affecting the peripheral nervous system. GBS is characterised by muscle weakness and paralysis. It typically starts with weakness, tingling, or numbness in the limbs. Symptoms can progress rapidly, leading to paralysis that may last from six months to a year. The syndrome affects nerves responsible for muscle movement and sensation. While it can occur at any age, it is more common in adult males. Causes and Triggers The exact cause of GBS remains unknown. However, it often follows infections, either bacterial or viral. The immune system mistakenly attacks the body’s nerves after such infections. Some rare cases have been linked to va...
Read more

Bharat Cancer Genome Atlas

Image
  The Indian Institute of Technology Madras recently launched the Bharat Cancer Genome Atlas (BCGA). This initiative aims to enhance cancer research in India. It addresses the under-representation of Indian genetic data in global cancer studies. The launch comes ahead of World Cancer Day and marks the increasing cancer incidence in the country. Overview of the Bharat Cancer Genome Atlas The BCGA is a comprehensive database of genetic variants linked to breast cancer in India. It collects data from breast cancer patients across the country. The goal is to identify specific biomarkers for early detection and develop targeted treatment strategies. Significance of the Initiative This initiative is crucial for understanding the unique genetic landscape of Indian cancers. The database will aid in the identification of cancer-specific biomarkers. It will also facilitate the development of diagnostic kits and targeted therapies tailored to the Indian population. Research and Collaboration...
Read more

WEF’s “Blueprint to Close the Women’s Health Gap” Report

Image
  The World Economic Forum (WEF) has released a report denoting the economic potential of addressing women’s health issues. Titled “Blueprint to Close the Women’s Health Gap,” the report reveals that improving women’s health could contribute an estimated $400 billion to global GDP by 2040. It identifies nine critical health conditions impacting women’s lives and puts stress on the need for targeted research and investment. Women’s Health Disparities Women experience 25% more years of poor health compared to men. This disparity is largely due to insufficient research and funding focused on women-specific health conditions. The report indicates that women are often overlooked in clinical trials, particularly in areas like ischemic heart disease and migraine , where only 10% include sex-specific data. Key Health Conditions Identified The report categorises nine health conditions into two groups – lifespan and health span conditions. Lifespan conditions include maternal hypertensive d...
Read more